Somero Enterprises (SOM) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
15 Sep, 2026Executive summary
Revenue grew 22% year-over-year to $48.7m in H1 2026, with broad-based growth across all regions and most product lines, driven by stabilizing markets and increased customer activity.
Adjusted EBITDA rose 59% to $10.1m, with margin improving to 20.7% from 15.9% year-over-year, reflecting operational leverage.
Strong cash generation resulted in net cash of $29.6m and $9.2m returned to shareholders via dividends and buybacks.
Strategic initiatives under the Fortify, Innovate, Amplify framework delivered increased new customer revenue and successful product launches.
Governance enhancements included board refresh, staggered terms, and improved shareholder alignment.
Financial highlights
H1 2026 revenue rose 22% year-over-year to $48.7m; gross margin held at 52.8%.
Adjusted EBITDA: $10.1m, up 59% year-over-year; margin at 20.7%.
Net income: $6.7m, up from $2.6m last year; adjusted net income per share: $0.12 (2025: $0.06).
Operating cash flow up 76% to $7.1m; net cash at $29.6m, no debt.
Returned $9.2m to shareholders via $5.8m buybacks and $3.4m dividends; interim dividend per share: $0.05.
Outlook and guidance
Upgraded FY2026 guidance: revenue ~$95m, adjusted EBITDA ~$19.5m, year-end net cash ~$29m, assuming full execution of expanded $12m share buyback.
Second half expected to be broadly in line with the first, with similar margins and healthy backlogs.
Guidance considered conservative due to European uncertainties; U.S. outlook remains strong.
Latest events from Somero Enterprises
- H1 2026 trading exceeded expectations, with FY 2026 revenue now forecast above market consensus.SOM
H1 2026 TU - Major resolutions failed to pass, triggering a governance review and board refresh commitment.SOM
AGM 2026 - Revenue fell 19%, but innovation and cost actions supported margins and cash flow.SOM
H2 2025 - H2 2025 saw improved trading and new product traction, but FY 2025 revenue fell to $88.9m.SOM
H2 2025 TU - Revenue down 23% and EBITDA down 48%, but guidance and new products drive optimism.SOM
H1 2025 - All resolutions passed, with leadership reaffirming commitment to innovation and partnership.SOM
AGM 2025 - Revenue fell 12% and profits declined, but new products and strong liquidity support H2 growth.SOM
H1 2024 - All resolutions passed, directors re-elected, and key shareholder questions addressed.SOM
AGM 2024 - 2024 revenue declined 9.6% as North America and Australia softened, but 2025 growth is expected.SOM
H2 2024